Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in Africa

Prospective Surveillance for Cardiac Adverse Events in Healthy Adults Receiving Modified Vaccinia Ankara Vaccines: A Systematic Review

(2013) Marnie L. Elizaga et al.   PLoS One

A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

(2012) Michael C. Keefer et al.   PLoS One

Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events

(2012) Claudia Schmidt et al.   Human Vaccines & Immunotherapeutics

Vaccine-induced HIV seropositivity: A problem on the rise

(2011) Eva Van Braeckel et al.   JOURNAL OF CLINICAL VIROLOGY

A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus

(2010) Eftyhia Vardas et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Vaccine-Induced HIV Seropositivity/Reactivity in Noninfected HIV Vaccine Recipients

(2010) Cristine J. Cooper   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine

(2010) Sandhya Vasan et al.   PLoS One

Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa

(2010) Walter Jaoko et al.   PLoS One

A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C-Modified Vaccinia Ankara Virus Vaccine Candidate in Indian Volunteers

(2009) Vadakkuppatu Devasenapathi Ramanathan et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three Continents

(2008) M. J. Boaz et al.   Clinical and Vaccine Immunology

Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa

(2008) Walter Jaoko et al.   VACCINE